Table 5 Fasciocutaneous
Author | Flap type | Healing rate | Complications | Mean f/u (months) | Minimum f/u (months) | Maximum f/u (months) |
|---|---|---|---|---|---|---|
Adam et al. | Saphenous fasciocutaneous (n = 5) Fasciocutaneous posterior calf (n = 3) | 100% | None | 64.8 | 12 | 120 |
Menderes et al. | Fasciocutaneous (n = 7) | 100% | Revision (n = 3) | 20 | 1 | 61 |
Misra et al. | Fasciocutaneous (n = 15) | 100% | Wound dehiscence (n = 1) | 13 | 3 | 24 |
Nahabedian et al. | Fasciocutaneous (n = 5) | 80% | Nonhealing (n = 1) | 81.6 | 48 | 120 |
Papaioannou et al. | Fasciocutaneous (n = 16) | 94 | Partial flap loss (n = 1) | 28 | 6 | 60 |
Siim et al. | Fasciocutaneous (n = 10) | 60% | Infection (n = 1) Partial vascularization (n = 1) Partial necrosis (n = 2) | 57.6 | 12 | 156 |
Suda et al. | Fasciocutaneous (n = 1) | 0% | Above-knee amputation (n = 1) | 37 | 13 | 61 |
Vaienti et al. | Island sural neurocutaneous flap (n = 15) | 100% | Hematoma (n = 2) Aseptic fistula (n = 1) | 18 | – | – |
Young et al. | Fasciocutaneous (n = 1) | 0% | Above-knee amputation (n = 1) | 33 | 5 | 96 |